Skip to main content

Why has Manitoba been so slow to approve the use of new and effective monoclonal antibodies.

 On Thursday November 25th, I asked the Minister of Health why her government has been so slow to approve the use of two monoclonal antibodies (MAbs)which have been shown to the very effective in reducing hospital and ICU needs and reducing deaths from COVID-19.   These monoclonal antibodies have been approved for use and have been used for the last three months in Ontario, and have been similarly approved for use in British Columbia and Alberta.  The use of these monoclonal antibodies have the potential to reduce the need for ICU beds from COVID and to reduce deaths.  Their use could potentially have decreased the need for ICU beds sufficiently that we would not have needed to transport patients hundreds of kilometers away from their homes in order to free up hospital space. My question and the Minister's response is below (from Hansard). 

MAbs for Early COVID Treatment
Approval for Use in Manitoba

Hon. Jon Gerrard (River Heights): Madam Speaker, two monoclonal antibodies, casirivimab and imdevimab–colloquially called mAbs–are remark­ably effective in the early treatment of COVID, decreasing the number of people having to go to the ICU or dying by up to 70 per cent. These mAbs are now widely used in BC, Alberta and Ontario, including in Sioux Lookout and Thunder Bay, but not in Manitoba, because this Province has not acted with the urgency needed.

      Why is the Province hesitating to approve these mAbs when they save lives and decrease ICU use and can enable Manitoba to return to elective surgeries and address the enormous backlog which we have now?

Hon. Audrey Gordon (Minister of Health and Seniors Care): I thank the member for–from River Heights for the question.

      Our gov­ern­ment continues to seek the advice and listen to the experts at Public Health, as well as the national advisory council on immunization. The best defence we have against COVID‑19 is for individuals to get vaccinated. When new drugs become available, once again, we seek the advice of public health experts.

      As you know, Madam Speaker, earlier this year, I also changed regula­tion to make it easier for us to add new drugs to the formulary, and I look forward to hearing more from Public Health as new drugs come to the market.

In addition to the question above, I commented on two other occasions on the failure of the government to quickly approve the use of the mAbs in Manitoba.  These comments are below: 

From my Comments on the Throne Speech – Thursday November 25th

The COVID pandemic continues and now is in the middle of the fourth wave. The projections from our chief public health officer, Dr. Brent Roussin, are that it will get worse.

      Already, many surgical and diag­nos­tic pro­cedures are being postponed. Postponed is a gov­ern­ment euphemism for cancelled, to be rescheduled at some unknown future date. It means the backlog of surgeries and diag­nos­tic tests will grow.

      It did not have to be this way. I have, for example, already written re­peat­edly to the Minister of Health to allow the use of two monoclonal antibodies, mAbs. These two are, spe­cific­ally, casirivimab, and imdevimab, and their use early in the course of COVID‑19 infection has been shown to reduce deaths and to reduce the number of individuals who need ICU care by up to 70 per cent.

      The reduction in the need for ICU care would be sufficient that surgeries would not have needed to be cancelled in the way they were. It's really unfor­tunate that Manitoba has been so slow to approve the use of mAbs. Currently, these mAbs are being used widely in Ontario, in Alberta and BC. Indeed, it's shocking that these mAbs can be used in Sioux Lookout and Thunder Bay, but can't be used in Winnipeg.

      Bob Dylan had a song, when will they ever learn. One wonders whether the current gov­ern­ment will ever learn.


From my Comments on a resolution calling from a Public Inquiry into the conduct of the Pandemic on Thursday December 2.

 In June 2021, Health Canada approved the use of two monoclonal antibodies, colloquially called mAbs, with the specific names casirivimab and imdevimab. These have been shown in rigorous scientific work to be very effective when given early in the course of a COVID infection in a person who is not vaccinated. They reduced the need for hospitalization and for ICU care. The results are very impressive with as much as a 70 per cent reduction in some cases.

      I wrote on October 11 and again on October 22nd to the Minister of Health to urge her to approve the use of these mAbs and then asked in QP last week. Ontario, BC and Alberta have already been using them for some time, including in Sioux Lookout in rural Ontario. But in Winnipeg, a hub of expertise in infectious diseases, we still can't use them. Ouch. I dread to consider how many people in Manitoba have died when they could have been saved if these agents had been approved here much more quickly, as they were in Ontario.

      Just because some in Manitoba have not got vaccinated doesn't mean they shouldn't be helped. These people may be misinformed but they are not bad people. They should be helped. They should not die when we can prevent it


Popular posts from this blog

Comparison between Manitoba and South Dakota shows dramatic impact of Physical Distancing

Manitoba implemented physical distancing measures in mid-March.  South Dakota has still not made physical distancing mandatory.   The result is a dramatic difference in the incidence of covid-19 viral infections between the two jurisdictions.   This graph shows the number of people with Covid-19 infections from March 27 to April 14.  Manitoba ( red line )  started leveling off about April 4 and has seen only a small increase in Covid-19 infections since then.   South Dakota ( blue line )   has seen a dramatic increase in Covid-19 infections since April 4.  Those who are skeptical of the impact of physical distancing in Manitoba should look at this graph! Data are from the Johns Hopkins daily tabulations

Standing up for Seniors

Yesterday in the Legislature I  asked the Minister of Health questions about the care of seniors in personal care homes in Manitoba.   I specfically called for the Minister to increase the training and staffing requirements for personal care homes in Manitoba to bring them up to date.   My questions, the Minister's comments and the Speaker's interjection are below:  Personal-Care-Home  Improvements - Need for Upgrades to Standards and Training Hon. Jon  Gerrard   (River Heights): Madam Speaker, we're very concerned this government is not adapting to the reality of caring for seniors who are living longer. Seniors living in our personal-care homes today have much more challenging health-care conditions than those who were in similar homes even five years ago, and yet the staffing formula, or minimal personnel requirement, is over 20 years old. Too few care aides and nurses are adequately trained to look after residents with dementia and multiple chronic health conditi

I cried today when I heard the report on the Maples Care Home disaster

Today the Pallister  government released the report on the tragedy which occurred at the Maples personal care home in October  to December 2020.   There were far too many people infected with COVID-19 (73 staff and 157 residents) and far too many deaths (56).  It did not have to be this way.  The central finding of the report was: "The review found that while pandemic plans had  been prepared and were in place, the site was not prepared for the significant reduction in available staff once they had been  exposed to COVID-19  and were required to self-isolate.  In addition, the urgency of requests for additional on-site staffing supports were not  fully understood until the situation became critical.   While additional staff were brought in, many were not skilled in providing long-term care services and  lacked training in infection prevention and control and specialized housekeeping skills."    Five  months before, Manitoba Liberals had warned the Premier three times that pre